We developed a sensitive, specific method for the low-molecular-mass thiols cysteine, cysteinylglycine, glutathione, and homocysteine and validated the method for measurement of glutathione in blood.
merous important roles in metabolism and homeostasis. These compounds act as part of an antioxidant defense network, including radical quenching, and altered thiol concentrations in plasma have been linked to specific pathologic conditions (1 ) .
GSH is the principal nonprotein thiol compound, acting as a major bio-reducing agent (2 ) . The intracellular concentration of GSH in mammalian cells is in the millimolar range (0.5-10 mmol/L), whereas micromolar concentrations are typically found in plasma (3 ) . Cys is a critical substrate for protein synthesis and a rate-limiting precursor of GSH and taurine synthesis; with the other thiols (in particular GSH), it is involved in the transport/ storage of NO (4 ) . Hcy is a sulfur-containing amino acid that is formed from methionine, an essential amino acid derived from dietary protein. More than 80% of Hcy is found in plasma, mostly conjugated to proteins through disulfide bonding or as symmetrical disulfide homocystine, as mixed disulfide Hcy-Cys, or as a free thiol (Ͻ2%) (1, 5 ) . Mildly increased plasma Hcy concentrations have been associated with an increased risk for cardiovascular and cerebrovascular diseases in men (6 ) , and highly increased plasma and urine concentrations are a clinically relevant indicator of a rare, hereditary metabolic disorder called homocystinuria (7 ) . CysGly is, after Cys, the most abundant thiol in plasma and is a product of enzymatic degradation of GSH. Reduced, free oxidized, and proteinbound forms of Cys, CysGly, GSH, and Hcy comprise the plasma redox thiol status (8 ) .
Although they play important roles in metabolism and homeostasis and their concentrations in blood (plasma and erythrocytes) could possibly serve as biomarkers of redox status, biological thiols and disulfides are present in blood in low concentrations, and blood is a complex matrix. There thus is a need to develop new rapid, sensitive, specific, and accurate methods for their determination.
Several methods have been proposed for the measurement of thiols and disulfides in plasma, most of them based on derivatization procedures (1, 9 ) . A review of methods for GSH and related thiols has been published (3 ). Here we present a new, abbreviated technique that has been optimized for the speciation and determination of the thiols Cys, CysGly, GSH, and Hcy.
Materials and Methods chemicals and stock solutions p-Hydroxymercurybenzoate
[4-(hydroxymercuric)benzoic acid, sodium salt; PHMB] was purchased from Sigma. We prepared a 0.01 mmol/L stock solution of PHMB by dissolving the sodium salt in 0.01 mol/L NaOH to improve its solubility; we stored the solution at 4°C and diluted it just before use. The precise PHMB concentrations in the solutions were determined from the absorbance at 232 nm (⑀ 232 ϭ 1.69 ϫ 10 4 cm Ϫ1 ⅐ mol Ϫ1 ⅐ L). l-Cys was purchased from Merck, and reduced GSH, d,l-Hcy, dithiothreitol (DTT), nitrosoglutathione (GSNO), and CysGly were purchased from Sigma. Oxidized glutathione (GSH ox ) was purchased from Fluka. Perchloric acid and EDTA disodium salt were from J.T. Baker.
We prepared a 0.2 mol/L (pH 9.0) buffer solution from NaH 2 PO 4 monohydrate and anhydrous Na 2 HPO 4 (BDH; Merck). Trifluoroacetic acid (TFA) and methanol for reversed-phase chromatography (RPC) were purchased from Carlo Erba.
We prepared NaBH 4 solutions more concentrated than 10 g/L by dissolving the solid reagent (Merck; minimum assay Ͼ96%) in a solution of 30 g/L NaOH. The solutions were microfiltered through a 0.45 m membrane and stored in a refrigerator. We prepared dilute solutions of NaBH 4 by appropriately diluting the stock solutions, the total NaOH concentration being kept at 3 g/L, unless specified. A 240 -260 g/kg hydrazine standard solution (cat. no. 53847) was purchased from Fluka Chemie, and the optimized concentration added to a NaBH 4 solution containing 3 g/L NaOH (see Table 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol51/issue6/).
We prepared the stock solution of Br Ϫ /BrO 3 Ϫ by dissolving the solid reagents (Carlo Erba), keeping an ϳ5:1 molar ratio on the basis of stoichiometry of redox reaction. Addition of a moderate excess of Br Ϫ guaranteed complete conversion of bromate to Br 2 .
Water deionized with a Milli-Q system (Millipore) was used throughout.
sample collection and storage
We obtained human blood (1.0 mL) from healthy volunteers by venipuncture of an antecubital vein with a butterfly needle and collected the blood into evacuated tubes containing EDTA; we obtained blood from cardiopathic patients by catheterization of the coronary sinus after obtaining informed consent. The protocol was approved by the internal scientific review board and ethics committee. In brief, 5 patients with left ventricular dysfunction and angiographically normal coronary arteries at routine cardiac catheterization, receiving the diagnosis of idiopathic dilated cardiomyopathy (DCM), underwent additional catheterization of the coronary sinus. Blood samples (1 mL) were collected from the coronary sinus by syringe from patients at rest, during atrial pacing (pulse, 110 and 130), and in the recovery phase (1, 5, 15 , and 30 min) to assess markers of oxidative stress; the blood samples were immediately injected into evacuated tubes containing EDTA.
Blood samples were obtained, after consent, from 5 control patients (with coronary artery disease and normal left ventricular function) by venipuncture of an antecubital vein with a butterfly needle and were collected in evacuated tubes containing EDTA. Samples were taken with the patients in a resting condition at 0, 5, 15, and 30 min to assess the within-and between-person variability of GSH status over time.
For analysis of reduced and oxidized GSH in whole blood, we mixed 500 L of the collected blood with 500 L of 100 g/L trichloroacetic acid immediately after collection and centrifuged the acidified sample at 10 000 g for 15 min at 4°C. The supernatant was divided in aliquots and stored at Ϫ80°C until use.
sample derivatization procedure
Fresh thiol stock solutions (ϳ2-5 g/L) were prepared daily by dissolving the powder in 10 mL/L TFA. For calibration experiments, thiols were derivatized by diluting the stock solution in 1 mL/L TFA containing a stoichiometric amount or a moderate excess of PHMB (25°C). After a reaction time of 50 min at room temperature (20 Ϯ 1°C), the solutions were injected into the RPC system.
For each blood sample, we diluted 2 aliquots (50 L each) of the supernatant coming from the deproteinized whole blood in 200 L of 0.2 mol/L sodium phosphate buffer (pH 9.0) and 1 mmol/L EDTA. One aliquot was mixed with 750 L of 1 mL/L TFA containing 100 mol/L PHMB for measurement of reduced GSH. To the other aliquot, we added 0.5 mmol/L DTT and incubated it at 37°C for 20 min to reduce the GSH and glutathione disulfide (GSSG) for measurement of total GSH (GSH tot ). After 20 min, the reaction was terminated by addition of 750 L of 1 mL/L TFA containing an excess of PHMB to complex the GSH and the DTT. The GSSG concentration was calculated as the difference between the concentrations of GSH tot and GSH. To evaluate the optimum DTT concentration for complete conversion of GSSG to GSH, we investigated the concentration-response curve for DTT in the reaction mixture, varying the DTT concentration from 0.1 to 10 mmol/L. We also studied the kinetics of DTT reduction were; the reaction appeared to be complete at 20 min and remained unchanged after 30 min of incubation at 37°C (data not shown). In the adopted conditions, the mean (SD) reduction yield was 98 (2)%.
stability of thiol-PHMB complexes
All of the thiol solutions, once complexed, were stable for the length of the working day if kept at room temperature and for 3 month (time tested) if stored at Ϫ20°C.
chromatographic instrumentation
For RPC, we used a HPLC gradient pump (P4000; ThermoQuest) equipped with a mechanical degassing system (SC1000; ThermoQuest), a Rheodyne 7125 injector (Rheodyne), and a 35-L injection loop. A diode array detector (DAD; UV6000; ThermoQuest) equipped with a flow cell with a 5-cm pathlength was located at the end of the column, just before and in series with the cold vapor generation atomic fluorescence spectrometry (CVGAFS) detection system. This detection system (DAD-CVGAFS) allowed simultaneous acquisition of ultraviolet/visible absorbances and mercury-specific chromatograms.
chromatographic conditions
Separations were carried out with a Vydac C 4 reversedphase column [150 ϫ 4.6 mm (i.d.); silica particle size, 5 m; porosity, 300 Å; code 214TP5415]. All solutions were filtered through a 0.45 m cellulose acetate filter (Millipore). The pump flow rate was 1.0 mL/min. Samples were eluted with a 45-min linear gradient from 100% A (1 mL/L TFA solution) to 30% B (per liter, 950 mL of methanol and 50 mL of 1 mL/L TFA solution). The PHMB-DTT complex eluted at 28 min and did not interfere with the measurement of other thiols.
chemical vapor generation with afs detection
A schematic diagram of the continuous flow (CF) mercury chemical vapor generator modified for on-line digestion of organic mercury in a miniaturized Ar/H 2 flame is shown in Fig. 1 of the online Data Supplement, and a detailed description of the apparatus has been reported previously (10 ) . Briefly, on-line digestion was performed at room temperature in a 30-cm-long reaction coil with bromine, generated in situ by KBr/KBrO 3 in HCl medium. The subsequent reduction of Hg II to Hg 0 was performed in a knitted reduction coil with NaBH 4 solution containing hydrazine to control the potential quenching effect of Br 2 on mercury fluorescence (10 ) . The use of short knitted coils guaranteed effective mixing of reactants and control of diffusion processes with resulting symmetric, well-shaped chromatographic peaks (11 ) . Two independent peristaltic pumps were used for mercury vapor generation and for waste removal from the gas-liquid separator. A laboratory-made manifold was used for mixing reagents and for addition of the argon carrier gas to the reaction mixture. The manifold consisted of a series of independent mixing T-junctions (0.5 mm i.d.) drilled into a Teflon block. The gas-liquid separator was made from borosilicate glass and was 60 mm long with a 10 mm i.d. All reagent concentrations, reaction coil dimensions, and flow rates were optimized, as reported previously (10 ) , and are summarized in Table 1 of the online Data Supplement.
The mercury vapor coming from the gas-liquid separator was delivered into the atomizer, which was a miniature Ar/H 2 diffusion flame supported on a simple quartz tube (4 mm i.d.). Despite the fact that mercury vapor is in its atomic state and does not require the atomization step, we found that the Ar/H 2 diffusion flame was necessary to remove interferences in the atomization/detection step generated by volatile species arising from the complex matrix during the postcolumn chemical reactions.
We used a laboratory-assembled nondispersive atomic fluorescence detector (12 ) equipped with an EDL2 System (Perkin-Elmer) and an electrodeless discharge mercury lamp (EDL).
The output data from the lock-in amplifier were collected at 1 Hz with a personal computer (600 MHz Pentium ® ; Intel Corporation) equipped with a data acqui- Results and Discussion speciation and determination of PHMB complexes in solutions by RPC-CVGAFS Shown in Fig. 1 are RPC-CVGAFS chromatograms for Cys-, CysGly-, Hcy-, and GSH-PHMB complexes (6.5, 9.7, 6.5, and 8.0 mol/L in the sample injected, respectively), obtained with the optimized conditions.
We constructed calibration curves for thiol-PHMB complexes (injected concentration, 0.01-1400 mol/L) by injecting calibrators in duplicate as described in the Materials and Methods. Calibration curves were linear over 3 orders of magnitude, the dynamic linear range spanning injected concentrations of 0.01-1400 mol/L. The fitting results of the calibration curves performed under the optimized conditions (Table 1) were obtained by plotting the areas of RPC-CVGAFS chromatogram peaks as a function of thiol-PHMB complex concentration injected. The retention times and concentration detection limits (LODc) are shown.
The LODc values, calculated from the calibration curves and based on the concentrations giving a signal 3 times the baseline noise, were 1, 1, 0.6, and 0.8 nmol/L for Cys, CysGly, Hcy and GSH, respectively.
The complexation ratio between the mentioned thiols and PHMB has been demonstrated to be 1:1; therefore, the slopes for the 4 thiol-PHMB complexes should be comparable. The different sensitivities shown in Table 1 are attributable to the different yields for on-line oxidation of these complexes by bromine in the oxidation coil (see Fig.  1 in the online Data Supplement). This could depend on the different stabilities of the thiol-PHMB complexes, which were attributable to the different pK a values for the ϪSH group of the thiols (13 ).
GSH and GSSG measurements in whole blood
We applied the RPC-CVGAFS method to the measurement of GSH and GSSG in whole peripheral blood from 5 healthy donors. The mean (SD) values for GSH and GSSG concentrations were 539.4 (70.9) and 90.4 (52.7) mol/L, respectively, with the percentage of GSSG/GSH tot ranging between 1% and 21%.
The within-day reproducibility of the assay for GSH was determined with 15 underivatized aliquots prepared independently from the whole-blood sample, and the between-day reproducibility was calculated from the analysis of 10 different underivatized aliquots of the supernatant from the whole-blood sample, prepared as described in the Materials and Methods and stored at Ϫ80°C, which was derivatized fresh each day for 10 days over a period of 1 month. The within-day CVs were 1.9% for GSH and 3.0% for GSSG. The between-day CVs, determined by assaying on 10 different days, were 2.8% for GSH and 4.0% for GSSG.
We evaluated recovery by adding known concentrations of GSH or GSSG (400 mol/L) to whole blood from a healthy donor (N3). The concentrations in samples with added glutathione were measured in 5 replicates. The mean (SD) recoveries were 103 (5)% for GSH and 98 (6)% for GSSG.
The RPC-DAD-CVGAFS chromatogram of a wholeblood sample (endogenous GSH, 23 mol/L), derivatized with PHMB and enriched with Cys-PHMB (19 mol/L in the sample injected), CysGly-PHMB (47 mol/L), and Hcy-PHMB (19 mol/L) is shown in Fig. 2 . The recovery of the added analytes, calculated on the basis of peak areas and calibration curves in 5 enriched samples, was 98 (3)%. The black line in Fig. 2 corresponds to the mercury-specific chromatographic trace; the gray line indicates the ultraviolet absorbance chromatogram at 254 nm; comparison of the traces reveals the better response of the CVGAFS detector compared with a conventional ultraviolet detector.
In the specific case of detection of GSH in whole blood, The concentrations were 6.5, 9.7, 6.5, and 8.0 mol/L, respectively, in the sample injected. AF, atomic fluorescence.
the sensitivity of the RPC-CVGAFS method is much higher that that required. Indeed, the total GSH concentration in whole blood ranges between 0.5 and 0.7 mmol/L, most of which originates from the GSH inside erythrocytes with ϳ0.2% from plasma. For this reason, we diluted our samples 40-fold before injection. Dilution of complex biological matrices is recommended to avoid or control for any matrix effects. For measurement of the other thiols, greater sensitivity is required because Cys, CysGly, and Hcy are present in plasma and cells in the micromolar range.
behavior of GSNO in RPC-CVGAFS analysis
It is well known that the incorporation of NO into S-nitroso derivatives of thiols, such as Cys and, in particular, GSH, may serve to maintain over time the biological activity of NO (14 ) . Thus, the part of GSH in blood present as GSNO may have biological relevance. Recent studies have indicated that the concentrations of S-nitroso derivatives of thiols in plasma from healthy individuals are lower than reported previously and in the range of 30 -120 nmol/L (15, 16 ) . Although in physiologic conditions GSNO represents a small part of total glutathione (GSH tot ϭ GSH ϩ GSNO ϩ 2 GSSG), it should not be overlooked in thiol speciation studies because of the potential role of GSNO in many pathologic situations (17 ) .
Because the RPC-CVGAFS method is based on the interaction of a mercurial probe with GSH, it was important to investigate the behavior of GSNO to understand whether the eventual presence of GSNO in the sample affects the measurement of reduced GSH or of GSSG. For this purpose, we added a known concentration of GSNO (250 mol/L) to whole blood from healthy donors and treated the samples according to the procedure described in the Materials and Methods. We determined the recovery of GSNO in both nonreduced samples and in samples treated with DTT. The concentrations in samples with added GSNO were determined in 3 replicates. GSNO was not detected in the nonreduced sample, but was recovered in the sample treated with DTT [mean recovery 98 (2)%], indicating that the PHMB does not react with GSNO unless reduced by DTT. Thus, GSH tot can be expressed as:
where
When the GSNO concentration is not known, we suggest that the oxidized glutathione (GSH ox) be expressed with more confidence as the difference from Eq. 1:
GSH and GSH ox in patients with idiopathic DCM during chronotropic stress
We applied the RPC-CVGAFS method to the determination of reduced GSH and GSH ox in blood samples from patients with DCM during chronotropic stress (18 ) . The protocol included sampling at rest (time points B1 and B2 in Fig. 3 ), after 3 min of pacing at a pulse rate of 110 (time point P110), after 3 min of pacing at a pulse rate of 130 (time point P130), and during recovery (time points R1, R5, R15, and R30, after 1, 5, 15, and 30 min, respectively). We also evaluated the GSH ox /GSH tot ratio in the peripheral blood of 5 control patients (with coronary artery disease and normal ventricular function) at 0, 5, 15, and 30 min to assess the within-and between-person variability of GSH status over a time period analogous to the chronotropic stress test. The trends of GSH and GSH ox concentrations in the 5 DCM patients (Pt1, Pt2, Pt3, Pt4 and Pt5, respectively) under the different study conditions are shown in Fig. 2 of the online Data Supplement, whereas Fig. 3 shows the trends of the GSH ox /GSH tot ratio in the same patients (panels A and B) and in the 5 controls (panel C). We observed no significant variations in GSH status in the 5 controls examined, with the GSH tot concentration ranging between 408 and 724 mol/L in the whole-blood sample, and the GSH ox /GSH tot ratio ranging between 5% and 28%, without notable changes over time.
In the DCM patients, GSH and GSH ox concentrations and the GSH ox /GSH tot ratio at rest (samples B1 and B2) were in the same range as for the controls, the GSH ox / GSH tot ratio ranging between 11% and 28%. However, in all 5 DCM patients, the GSH ox /GSH tot ratio in the coronary sinus blood tended to increase during chronotropic stress. In 1 of the 5 patients (Pt4 in Fig. 3B ), the increase in the ratio was delayed and the recovery was unappreciable Clinical Chemistry 51, No. 6, 2005 during the test time. In patient 5 (Fig. 3B, Pt5 ) the study was prematurely interrupted at 15 min of recovery because of displacement of the coronary sinus catheter and inability to sample blood. In the other 3 patients (Fig. 3A) , the GSH ox /GSH tot ratio tended to decrease during recovery. These data indicate that reduction of GSH ox , de novo synthesis in erythrocytes of GSH, or GSH secretion by myocardium tissues or endothelial cells may have occurred in the recovery phase to counteract a putative oxidative stress induced by pacing in the myocardium.
Emotional stress also affects the GSH ox /GSH tot ratio. Of the 5 cases examined in the second sampling before the chronotropic stress (B2) the GSH ox /GSH tot ratio was not altered in patients 1 and 4, but it reached 30% in patient 3, 55% in patient 5, and 70% in patient 2.
No data have been reported in the literature to which our results can be compared, mainly because no studies measuring acute changes of markers of oxidative stress in patients with DCM have been performed. However, recent data suggest that in these patients, myocardial ischemia may occur during stress as a consequence of coronary microvascular dysfunction (19, 20 ) . Accordingly, changes in markers of oxidative stress in DCM patients may reflect myocardial ischemia. It is known that GSH improves the recovery of myocardial mechanical function after ischemia-reperfusion in rat heart, an effect that may be related to the detoxification of peroxynitrite by GSH and the stimulation of soluble guanylate cyclase (21 ) . In a dog model, it has been observed that, parallel to increased lipid peroxidation, reduced GSH gradually decreased in coronary sinus blood sampling during early reperfusion after myocardial ischemia (22 ) .
comparison of RPC-CVGAFS with other methods
With the described analytical conditions we could analyze 4 samples/h (run-to-run time of 15 min, including column equilibration). Cys and CysGly are not baseline separated (t R ϭ 4.88 and 5.03 min, respectively), and Hcy elutes at 7.21 min. The cost of the mercurial probe PHMB is low, and PHMB-derivatized samples are stable at pH 2-8.5 at Ϫ20°C.
The proposed method, as well as all of the methods that use the specific derivatization of ϪSH groups, is not capable of monitoring disulfides directly, requiring a reduction step for detection of oxidized thiols.
A comparison of the LODc values for published methods for thiol speciation and determination with the LODc for the RPC-CVGAFS method is shown in Table 2 of the online Data Supplement. Detection limits for the RPC-CVGAFS method are comparable to those obtained by liquid chromatography with electrochemical detection and enzymatic assays and are approximately 2 orders of magnitude higher than the LOD for capillary electrophoresis with laser-induced fluorescence detection. RPC-CVGAFS is rather inexpensive compared with capillary electrophoresis with laser-induced fluorescence detection Fig. 3 . Effect of chronotropic stress on the redox state of glutathione in whole blood from patients with DCM during chronotropic stress and in control patients.
(A), GSH ox /GSH tot ratio in patients 1, 2, and 3 (Pt1, Pt2, and Pt3); (B), GSH ox /GSH tot ratio in patients 4 and 5 (Pt4 and Pt5). (C), GSH ox /GSH tot ratio in 5 control patients with coronary artery disease and normal left ventricular function at 0, 5, 15, and 30 min.
and liquid chromatography-mass spectrometry, although liquid chromatography-mass spectrometry offers good sensitivity and unique selectivity.
Electrochemical detection has the advantage of detecting both disulfides and reduced thiols, without requiring any derivatization step. However, most of the liquid chromatography detection methods for thiols require the use of mercury electrodes (23 ) rather than the more common carbon electrode (24 ) because thiols have a high overpotential for electrooxidation at ordinary carbon electrodes. In addition, Au/Hg electrodes (chemically modified or not) are characterized by long-term instability during both experimental operation and storage, and at high oxidation potentials, many compounds (e.g., oxygen) may cause interference (24, 25 ) .
Expensive reagents are necessary for immunoassaybased methods, although the labor costs are lower and the throughput is higher. However, simultaneous determination of thiols is not possible with immunoassays.
